A PROSPECTIVE STUDY ON QUALITY OF LIFE IN PATIENTS WITH ARTHRITIS
Objective: Patient counseling can scientifically improve the physical and mental symptoms of certain diseases that could be a relief to the patient.
Non-pharmacological approaches could be an alternative to the drug therapy. Health issues affecting the quality of life (QoL) are to be studied to
understand the patientâ€™s physical, mental, emotional, and social functioning.
Methods: The present study involves prospective analysis of QoL in men and women with arthritis. The methodology involves the collection and
documentation of general information of the patient including personal history, family background, clinical findings, investigations, and medical illness
associated with arthritis. Further, the QoL is documented using a specific questionnaire designed to assess the impact of arthritis and their complications.
Results: It can be seen that there is no significant changes in the physical and mental component score (MCS) in between the type of arthritis, but
there is an extremely significant (p<0.05) values were obtained when compared between pre- and post-counseling phases of physical and MCS.
Conclusion: Patients counseling plays a major role in the management of signs and symptoms among patients with arthritis. The non-pharmacological
method is also be used for the management of arthritis.
Keywords: Quality of life, Arthritis, Patient counseling, Questionnaire, Physical component score, Mental component score.
1. Usenbo A, Kramer V, Young T, Musekiwa A. Prevalence of arthritis
in Africa: A systematic review and meta-analysis. PLoS ONE
2. Reid MC, Shengelia R, Parker SJ. Pharmacologic management
of osteoarthritis-related pain in older adults. Am J Nurs
2012;112 3 Suppl 1:S38-43.
3. Brosseau L, Welch V, Wells G, DeBie R, Gam A, Harman K, et al.
Low level laser therapy (Classes I, II and III) for treating osteoarthritis.
Cochrane Database Syst Rev 2004;3:CD002046.
4. Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P.
Contribution of interleukin 17 to synovium matrix destruction in
rheumatoid arthritis. Cytokine 2000;12(7):1092-9.
5. Kirkley A, Birmingham TB, Litchfield RB, Giffin JR, Willits KR,
Wong CJ, et al. A randomized trial of arthroscopic surgery for
osteoarthritis of the knee. N Engl J Med 2008;359(11):1097-107.
6. Chan KW, Felson DT, Yood RA, Walker AM. The lag time between
onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis
7. Bridges PS. Prehistoric arthritis in the Americas. Annu Rev Anthropol
8. Won HY, Lee JA, Park ZS, Song JS, Kim HY, Jang SM, et al. Prominent
bone loss mediated by RANKL and IL-17 produced by CD4 T cells in
TallyHo/JngJ mice. PLoS One 2011;6(3):e18168.
9. Vanitallie TB. Gout: Epitome of painful arthritis. Metabolism 2010;59
10. Corbacho MI, Dapueto JJ. Assessing the functional status and quality
of life of patients with rheumatoid arthritis. Rev Bras Reumatol
11. Whalley D, Mckenna SP, de Jong Z, Van der Heijde D. Quality of life
in rheumatoid arthritis. Br J Rheumatol 1997;36(8):884-8.
12. Bajraktari IH, Teuta BÃ‡, Vjollca SM, Bajraktari H, Saiti V, Krasniqi B,
et al. Demographic features of patients with rheumatoid arthritis in
Kosovo. Med Arch 2014;68(6):407-10.
13. Pawlowska J, Smolenska Z, Daca A, Witkowski JM, Bryl E. Older
age of rheumatoid arthritis onset is associated with higher activation
status of peripheral blood CD4
T cells and disease activity. Clin Exp
14. Breedveld FC. Osteoarthritis â€“ The impact of a serious disease.
Rheumatology (Oxford) 2004;43 Suppl 1:i4-8.
15. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH,
et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation
of their monitoring: Results of an international, cross-sectional study
(COMORA). Ann Rheum Dis 2014;73(1):62-8.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.